| ²é¿´: 426 | »Ø¸´: 3 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
Çå·çÁÁÒø³æ (СÓÐÃûÆø)
|
[½»Á÷]
febuxostatÓÐÉÏÊÐÂð?
|
||
| febuxostatÓÐÉÏÊÐÂð£¿ÉÏÊеļÁÐͺ͹æ¸ñ£¿ÒѾ²éÁ˺þ㬺ÃÏñûÓп´µ½ÓÐÉÏÊУ¬Çë´ó¼ÒÖ¸½Ì£¬°ïÎÒ²é²é |
» ²ÂÄãϲ»¶
292ҩѧµ÷¼Á
ÒѾÓÐ1È˻ظ´
Ò½Ò©Ñз¢Êý¾Ý¿â×ÊÔ´
ÒѾÓÐ4È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ80È˻ظ´
slimdell
½ð³æ (³õÈëÎÄ̳)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 1470.2
- ºì»¨: 1
- Ìû×Ó: 38
- ÔÚÏß: 15.9Сʱ
- ³æºÅ: 97779
- ×¢²á: 2005-11-09
- רҵ: ÁÙ´²Ò©Àí
|
ÏÖÔÚ»¹ÔÚÃÀ¹ú×öIIIÆÚÁÙ´²ÊÔÑé http://www.clinicaltrials.gov/ct/show/NCT00430248?order=1 Sponsored by: TAP Pharmaceutical Products Èç¹ûÒѾÉÏÊÐÁ˵ϰ£¬TAP¹«Ë¾²»»á¼ÌÐøÔÚIIIÆÚÉϼÌÐø»¨Ç®°É£¨²»ÊÇеÄÊÊÓ¦Ö¢£© |
2Â¥2007-05-31 20:23:14
wyj970
ľ³æÖ®Íõ (ÎÄ̳¾«Ó¢)
- DRDEPI: 2
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 62274.2
- ºì»¨: 7
- Ìû×Ó: 17290
- ÔÚÏß: 910.9Сʱ
- ³æºÅ: 90306
- ×¢²á: 2005-09-01
- רҵ: Ò©¼Áѧ

3Â¥2007-06-07 18:21:19
pjkpn4
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 1121.7
- É¢½ð: 48
- ºì»¨: 1
- Ìû×Ó: 156
- ÔÚÏß: 32.5Сʱ
- ³æºÅ: 73621
- ×¢²á: 2005-06-09
- ÐÔ±ð: GG
- רҵ: ÊýÂÛ
4Â¥2007-06-07 18:34:37









»Ø¸´´ËÂ¥
30